ArticleFrontiers in oncology2014
Novel biologic therapies for thymic epithelial tumors.
Article in Frontiers in oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 11 citations in OpenAlex.
- Immunotherapy in thymic epithelial tumors: tissue predictive biomarkers for immune checkpoint inhibitors.Exploration of targeted anti-tumor therapy · 2024Review
- Pan-cancer Analysis Reveals SRC May Link Lipid Metabolism and Macrophages.Iranian journal of biotechnology · 2023Article
- Immunotherapy for thymoma.Journal of thoracic disease · 2020Review
- Pan-Cancer Landscape Analysis Reveals RecurrentJCO precision oncology · 2020Article
- Immune checkpoint inhibitors for treatment of thymic epithelial tumors: how to maximize benefit and optimize risk?Mediastinum (Hong Kong, China) · 2019Article
- WT1 as an immunotherapy target for thymic epithelial tumors: a novel method to activate anti-tumor immunity.Mediastinum (Hong Kong, China) · 2019Article
- Uncommon efforts for an uncommon tumor: the case for development of newer systemic therapies for advanced thymic epithelial tumors.Mediastinum (Hong Kong, China) · 2018Article
- The Integrated Genomic Landscape of Thymic Epithelial Tumors.Cancer cell · 2018Article
- Expression of mesothelin in thymic carcinoma and its potential therapeutic significance.Lung cancer (Amsterdam, Netherlands) · 2016Article
- Novel Treatments for Thymoma and Thymic Carcinoma.Frontiers in oncology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.